Citigroup Inc Guardant Health, Inc. Call Options Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 10, 2024	BUY	$17.13 - $26.91 $2.53 Million - $3.97 Million	147,600 New	147,600 $3.04 Million
Q4 2022 Feb 09, 2023	SELL	$25.44 - $59.78 $1.27 Million - $2.98 Million	-49,900 Reduced 41.62%	70,000 $1.9 Million
Q3 2022 Nov 10, 2022	BUY	$43.66 - $61.0 $2.43 Million - $3.39 Million	55,600 Added 86.47%	119,900 $6.45 Million
Q2 2022 Aug 10, 2022	BUY	$28.82 - $77.35 $1.85 Million - $4.97 Million	64,300 New	64,300 $2.59 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.